Webster George J M, Reignat Stephanie, Brown David, Ogg Graham S, Jones Louise, Seneviratne Suranjith L, Williams Roger, Dusheiko Geoffrey, Bertoletti Antonio
Institute of Hepatology, University College London, 69-75 Chenies Mews, London WC1E 6HX, United Kingdom.
J Virol. 2004 Jun;78(11):5707-19. doi: 10.1128/JVI.78.11.5707-5719.2004.
The cytotoxic T-cell response in chronic hepatitis B virus (HBV) infection has been described as weak and mono- or oligospecific in comparison to the more robust virus-specific T-cell response present in resolved infection. However, chronic hepatitis B is a heterogeneous disease with markedly variable levels of virus replication and liver disease activity. Here we analyzed (both directly ex vivo and after in vitro stimulation) the HBV-specific CD8 T-cell responses against structural and nonstructural HBV proteins longitudinally in patients with different patterns of chronic infections. We found that the profiles of virus-specific CD8(+)-T-cell responses during chronic infections are highly heterogeneous and influenced more by the level of HBV replication than by the activity of liver disease. An HBV DNA load of <10(7) copies/ml appears to be the threshold below which circulating multispecific HBV-specific CD8(+) T cells are consistently detected. Furthermore, CD8(+) T cells with different specificities are differentially regulated during chronic infections. HBV core-specific CD8(+) T cells are associated with viral control, while CD8(+) T cells specific for envelope and polymerase epitopes can occasionally be found in the setting of high levels (>10(7) copies) of HBV replication. These findings have implications for the design of immunotherapy for chronic HBV infections.
与已清除感染中更强劲的病毒特异性T细胞反应相比,慢性乙型肝炎病毒(HBV)感染中的细胞毒性T细胞反应被描述为较弱且具有单特异性或寡特异性。然而,慢性乙型肝炎是一种异质性疾病,病毒复制水平和肝脏疾病活动程度差异显著。在此,我们纵向分析了不同慢性感染模式患者针对HBV结构和非结构蛋白的HBV特异性CD8 T细胞反应(包括直接体外分析和体外刺激后分析)。我们发现,慢性感染期间病毒特异性CD8(+) T细胞反应的概况高度异质性,更多地受HBV复制水平而非肝脏疾病活动的影响。HBV DNA载量<10(7)拷贝/ml似乎是一个阈值,低于该阈值时可持续检测到循环中的多特异性HBV特异性CD8(+) T细胞。此外,不同特异性的CD8(+) T细胞在慢性感染期间受到不同的调节。HBV核心特异性CD8(+) T细胞与病毒控制相关,而包膜和聚合酶表位特异性的CD8(+) T细胞偶尔可在HBV高复制水平(>